RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00495378
Recruitment Status : Terminated (This study was stopped due to slow enrollment after enrolling 25 of 200 patients.)
First Posted : July 3, 2007
Last Update Posted : December 20, 2016
Information provided by (Responsible Party):
Ortho Biotech Products, L.P.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : March 2003